Nirrin Technologies
Billerica, US · Founded 2017 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
BH
Bryan HassellExecutive Officer
DS
David SeldinDirector
DM
David MichaelDirector
MG
Matthew GunnisonDirector
DH
Debrah HermanChief Financial Officer
JH
Jonathan HartmannChief Executive Officer
JC
John C. HoDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$6.7MraisedJun 2026 · 23 investors · BiotechnologyRule 506(b)
▶$6.7MraisedJun 2026 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryan HassellExecutive Officer
- David SeldinDirector
- David MichaelDirector
- Matthew GunnisonDirector
- Offering amount
- $9.7M
- Amount sold
- $6.7M
- Proceeds to insiders
- $241K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedFeb 2024 · 20 investors · BiotechnologyRule 506(b)
▶$4.8MraisedFeb 2024 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Debrah HermanExecutive Officer
- David Carr MichaelDirector
- Matthew GunnisonDirector
- Gregory CresenziExecutive Officer
- David Michael SeldinDirector
- Offering amount
- $6M
- Amount sold
- $4.8M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.5MraisedOct 2021 · 1 investors · BiotechnologyRule 506(b)
▶$8.5MraisedOct 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David Michael SeldinExecutive Officer, Director
- Debrah HermanExecutive Officer
- Jonathan HartmannExecutive Officer, Director
- David Carr MichaelDirector
- John C. HoDirector
- Offering amount
- $8.5M
- Amount sold
- $8.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
